Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical resp...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, Derek Lee, Lili Yang
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Subjects:	stem cell engineering allogeneic cancer therapy off-the-shelf cell therapy chimeric antigen receptor (CAR) T cell receptor (TCR) graft-versus-host disease (GvHD)
Online Access:	https://www.mdpi.com/2073-4409/10/12/3497

Similar Items

Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T Cells
by: Alexandre Juillerat, et al.
Published: (2020-06-01)

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01)

Recent updates on allogeneic CAR-T cells in hematological malignancies
by: Shafieeh Mansoori, et al.
Published: (2024-09-01)

Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer
by: Zibai Lyu, et al.
Published: (2025-05-01)

Established and Emerging Treatments of Skin GvHD
by: Cornelia S. Link-Rachner, et al.
Published: (2022-02-01)

Editorial: Immunology of allogeneic hematopoietic stem cell transplantation
by: Carmelo Gurnari, et al.
Published: (2025-02-01)

Editorial: Rising stars: cell and stem cell transplantation 2022
by: Raffaella Greco, et al.
Published: (2024-01-01)

Novel therapies for graft versus host disease with a focus on cell therapies
by: Robert Zeiser, et al.
Published: (2023-10-01)

Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context
by: Valentine Wang, et al.
Published: (2025-01-01)

Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference
by: Stephanie A. Maier, et al.
Published: (2024-05-01)

Advantages and Applications of CAR-Expressing Natural Killer Cells
by: Wolfgang eGlienke, et al.
Published: (2015-02-01)

The impact of regulatory T cells on the graft-versus-leukemia effect
by: Carolina P. Pacini, et al.
Published: (2024-04-01)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
by: Hongnga T. Le, et al.
Published: (2020-02-01)

Regulatory T cell therapies: from patient data to biological insights
by: Kameron B. Rodrigues, et al.
Published: (2025-10-01)

Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation
by: Monika Lejman, et al.
Published: (2019-11-01)

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01)

Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
by: Ying Huang, et al.
Published: (2022-02-01)

Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review
by: Cristina Aparicio, et al.
Published: (2023-08-01)

Population pharmacokinetic modeling of vedolizumab for graft‐versus‐host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant
by: Timothy Waterhouse, et al.
Published: (2024-10-01)

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
by: Paul Shafer, et al.
Published: (2022-03-01)

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party
by: Olaf Penack, et al.
Published: (2023-12-01)

Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease
by: Diana M. Matthe, et al.
Published: (2023-08-01)

The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD following Hematopoietic Stem Cell Transplantation
by: Seyed Asadollah Mousavi, et al.
Published: (2016-12-01)

Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation – the Karolinska experience
by: Olle Ringdén, et al.
Published: (2024-08-01)

Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe
by: Ronja Langer, et al.
Published: (2024-03-01)

Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons
by: Mehdi Mohammadi, et al.
Published: (2016-04-01)

Editorial: 50 years of BMT: long-term outcomes and late complications after transplantation
by: Eleni Gavriilaki
Published: (2023-08-01)

Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease
by: Antonia-Maria Pausch, et al.
Published: (2021-05-01)

Impact of oral microbiota on pathophysiology of GVHD
by: Akira Yamamoto, et al.
Published: (2023-03-01)

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome
by: Huidong Guo, et al.
Published: (2022-04-01)

“Off-The-Shelf” allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges
by: Razan Mohty, et al.
Published: (2024-07-01)

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
by: Fabio Morandi, et al.
Published: (2020-07-01)

4SCAR2.0 therapy for the management of post-transplantation relapse of B-cell acute lymphoblastic leukemia
by: Rui Zhang, et al.
Published: (2023-11-01)

Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
by: Mauro Di Ianni, et al.
Published: (2024-01-01)

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
by: Brian C. Betts, et al.
Published: (2018-12-01)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
by: Dominik Schneidawind, et al.
Published: (2020-03-01)

Sclerotic chronic cutaneous graft-versus-host-disease following pseudoallogeneic chimeric antigen receptor T-cell therapy
by: Esther Choi, BS, et al.
Published: (2024-10-01)

Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1
by: Lukas Heger, et al.
Published: (2025-08-01)

Non-Invasive Diagnosis of Pediatric Intestinal Graft-Versus-Host Disease: A Case Series
by: Manuela Spadea, et al.
Published: (2022-03-01)

Treg cell therapy manufacturability: current state of the art, challenges and new opportunities
by: Janelle Stoops, et al.
Published: (2025-05-01)